Publications by authors named "Michael Chez"

Claim this Profile
E
Effectiveness and safety of perampanel by concomitant antiseizure medications: Insights from the real-world PERMIT Extension study.
Takamichi Yamamoto, Michael Chez, Dulce Campos, Simona Lattanzi, Sara Matricardi

Epilepsy Behav· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring proposed recommendations for immediate-use seizure medication: Treating both cluster and prolonged seizures with diazepam nasal spray.
Michael Chez, Pavel Klein, Danielle Becker, Jurriaan M Peters, Enrique Carrazana

Epilepsia Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient management of prolonged seizures and seizure clusters to prevent progression to a higher-level emergency: Consensus recommendations of an expert working group.
Jesus Eric Pina-Garza, Michael Chez, James Cloyd, Lawrence J Hirsch, Reetta Kälviäinen

Epileptic Disord· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness, safety and tolerability of perampanel by age group when used to treat people with focal and generalized epilepsy in clinical practice: The PERMIT Extension study.
James Wheless, Robert T Wechsler, Patricia Penovich, Eric Segal, Michael Chez

Epilepsy Behav· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the Expanded Access Program.
Robert J Flamini, Anne M Comi, E Martina Bebin, Michael G Chez, Gary Clark

Epilepsia· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposed anti-seizure medication combinations with rufinamide in the treatment of Lennox-Gastaut syndrome: Narrative review and expert opinion.
Raman Sankar, Michael Chez, J Eric Pina-Garza, Tracy Dixon-Salazar, J Robert Flamini

Seizure· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PROVE: Retrospective, non-interventional, Phase IV study of perampanel in real-world clinical care of patients with epilepsy.
Robert T Wechsler, James Wheless, Muhammad Zafar, Graham R Huesmann, Marcelo Lancman, Michael Chez

Epilepsia Open· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming presynaptic effects of VAMP2 mutations with 4-aminopyridine treatment.
Roxanne L Simmons, Haiyan Li, Baris Alten, Magda S Santos, Ruiji Jiang, Michael Chez

Hum Mutat· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Placebo-Controlled, Blinded, Crossover, Pilot Study of the Effects of Dextromethorphan/Quinidine for the Treatment of Neurobehavioral Symptoms in Adults with Autism.
Michael Chez, Shawn Kile, Christopher Lepage, Carol Parise, Bobbie Benabides

J Autism Dev Disord· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results.
Linda C Laux, E Martina Bebin, Daniel Checketts, Michael Chez, Robert Flamini

Epilepsy Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders.
Vincenzo Salpietro, Christine L Dixon, Hui Guo, Oscar D Bello, Jana Vandrovcova, Michael Chez

Nat Commun· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arginine vasopressin in cerebrospinal fluid is a marker of sociality in nonhuman primates.
Karen J Parker, Joseph P Garner, Ozge Oztan, Erna R Tarara, Jiang Li, Michael G Chez

Sci Transl Med· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Observations from a Placebo-Controlled, Crossover Study to Assess Use of Autologous Umbilical Cord Blood Stem Cells to Improve Symptoms in Children with Autism.
Michael Chez, Christopher Lepage, Carol Parise, Ashley Dang-Chu, Andrea Hankins

Stem Cells Transl Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and observations in a pilot study of lenalidomide for treatment in autism.
Michael Chez, Renee Low, Carol Parise, Tammy Donnel

Autism Res Treat· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune therapy in autism: historical experience and future directions with immunomodulatory therapy.
Michael G Chez, Natalie Guido-Estrada

Neurotherapeutics· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric safety of tizanidine: clinical adverse event database and retrospective chart assessment.
Herbert R Henney, Michael Chez

Paediatr Drugs· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children.
Michael G Chez, Tim Dowling, Pikul B Patel, Pavan Khanna, Matt Kominsky

Pediatr Neurol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability.
Michael G Chez, Quinn Burton, Timothy Dowling, Mina Chang, Pavan Khanna

J Child Neurol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy.
Anne M Connolly, Michael Chez, Elizabeth M Streif, Richard M Keeling, Paul T Golumbek

Biol Psychiatry· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of epileptiform EEG abnormalities in a sequential screening of autistic patients with no known clinical epilepsy from 1996 to 2005.
Michael G Chez, Mina Chang, Valerie Krasne, Carolyn Coughlan, Matthew Kominsky

Epilepsy Behav· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunizations, immunology, and autism.
Michael G Chez, Kathleen Chin, Paul C Hung

Semin Pediatr Neurol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurologic treatment strategies in autism: an overview of medical intervention strategies.
Michael G Chez, Shoaib Memon, Paul C Hung

Semin Pediatr Neurol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of EEG abnormalities in age-matched siblings of autistic children with abnormal sleep EEG patterns.
Michael G Chez, Thomas Buchanan, Mary Aimonovitch, Susan Mrazek, Valerie Krasne

Epilepsy Behav· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate.
Michael G Chez, Mary Aimonovitch, Thomas Buchanan, Susan Mrazek, Ryan J Tremb

J Child Neurol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome measures for clinical drug trials in autism.
Michael G Aman, Sherie Novotny, Carole Samango-Sprouse, Luc Lecavalier, Elizabeth Leonard, Michael Chez

CNS Spectr· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis